Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal pethidine added to bupivacaine versus ropivacaine for elective cesarean section pain control
IRCT20210415050976N10Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine + pethidine with Ropivacaine + pethidine (2 arms). Primary endpoint: Pain. Started Nov 2021; status: completed.
02
Drugs
pethidinebupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20210415050976N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050976N10.